Citations Appearing in 1989

  1. Arundel, P.A. Interactive simulation of nonuniform bolus and infusion dosing in linear compartmental models. Journal of Pharmaceutical Sciences 78:688-690, 1989.
  2. Bottorff, M.B., T.J. Hoon, J. H. Rodman, K.B. Ramanathan and P.A. Gerlach. Pharmacokinetics of urapidil in severe hypertension. Journal of Clinical Pharmacology 28:420-426, 1989.
  3. Boucher, B.A., J.H. Rodman, S.N. Rasmussen, T.C. Fabician, C.B. Watridge and G.S. Jaresko. Phenytoin pharmacokinetics in critically ill trauma patients. Clinical Pharmacology and Therapeutics 44:675-683, 1989.
  4. Boucher, B.A., C.B. Watridge, P. Turlapaty, S.N. Rasmussen, R. Achari and A.M. Bombassaro. Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653) – pharmacokinetics in patients following intravenous and intramuscular administration.Journal of Pharmaceutical Sciences 78:929-932, 1989.
  5. Cobelli, C. and A. Ruggeri. Optimal-design of sampling schedules for studying glucose kinetics with tracers. American Journal of Physiology 257:E444-E450, 1989.
  6. Drusano, G.L., A. Forrest, K.I. Plaisance and J.C. Wade. A prospective evaluation of optimal sampling theory in the determination of the steady-state pharmacokinetics of Piperacillin in febrile neutropenic cancer-patients. Clinical Pharmacology and Therapeutics 45:635-641, 1989.
  7. Evans, W.E., W.R. Crom, S. Degraaf, M.V. Relling, J.H. Rodman, J.A. Pieper and M.L. Christensen. Hepatic Drug clearance in children studies with indocyannine green as a model substrate. Journal of Pharmaceutical Sciences 78:452-456, 1989.
  8. Fletcher, C.V., J.A. Englund, B. Chinnock, B. Bean, D.M. Brundage and H.H. Balfour. Continuous infusion of high dose Acyclovir for serious herpes virus infections. Antimicrobial Agents and Chemotherapy 33:1375-1378, 1989.
  9. Grange, J.D., A. Gouyette, X. Amiot, J.F. Acar, L. Gutmann, P. Jallion, S. Islam and M.D. Kitzis. Pharmacokinetics of amoxycillin clavulanic acid in serum and ascitic fluid in cirrhotic patients. Journal of Antimicrobial Chemotherapy 23:605-611, 1989.
  10. Khan, A.Z. and L. Aarons. Design and analysis of protein-binding experiments. Journal of Theoretical Biology 140:145-166, 1989.
  11. Kinabo, L.D.B. and Q.A. McKellar. Current models in pharmacokinetics applications in veterinary pharmacology. Veterinary Research Communications 13:141-157, 1989.
  12. Koren, G., J. Klien, M. Greenberg, S.J. Soldin and H. Solh. Disposition of oral methotrexate in children with acute lymphoblastic-leukemia and its relation to 6- Mercaptopurine pharmacokinetics. Medical and Pediatric Oncology 17:450-454, 1989.
  13. Koren, G., A.N. Sandler, D. Daley, W.C.Whiting, L.C. Lau, J. Klien and P. Slavchenko. Relationship between the pharmacokinetics and the analgesic and respiratory pharmacodynamics of epidural sufentanil. Clinical Pharmacology and Therapeutics 46:458- 462, 1989.
  14. Launay, M.C., G. Milano, N. Namer, M. Frenay and A. Iliadis. A limited sampling procedure for estimating Adriamycin pharmacokinetics in cancer patients. British Journal of Cancer 60:89-92, 1989.
  15. Leonard, M.B., D.K. Stevenson, G. Koren and C.G. Prober. Vancomycin pharmacokinetics in very low birth weight neonates. Pediatric Infectious Disease Journal 8:282-286, 1989.
  16. Ludden, T.M. Population pharmacokinetics. Journal of Clinical Pharmacology 28:1059- 1063, 1989.
  17. Moore, M.J., J.J. Thiessen, S.J. Soldin, C. Erlichman and R.W. Hardy. Rapid development of enhanced clearance after high dose cyclophosphamide. Clinical Pharmacology and Therapeutics 44:622-628, 1989.
  18. Plaisance, K.I., R.J. Townsend, H.C. Standiford, A. Forrest and G.L. Drusano. Pharmacokinetic evaluation of 2 dosage regimens of Clindamycin phosphate. Antimicrobial Agents and Chemotherapy 33:618-620, 1989.
  19. Pronzato, L. and E. Walter. Experiment design in a bounded error context comparison with D optimality. Automatica 25:383-391, 1989.
  20. Rodvold, K.A., R.D. Pryka, J.C. Rotschafer and M. Garrison. Evaluation of a 2- compartment Bayesian forecasting program for predicting Vancomycin concentrations. Therapeutic Drug Monitoring 11:269-275, 1989.
  21. Santos, D., E.L. Marino and A. Dominguez-Gil. Study of disposition kinetics of the N-oxide derivative: a metabolite of picobenzide. European Journal of Drug Metabolism and Pharmacokinetics 14:19-22, 1989.
  22. Tsang, Y.C. and J.J. Thiessen. Competitive-binding of sulfamethazine and its nacetylated metabolite. Biopharmaceutics and Drug Disposition 10:465-479, 1989.
  23. Vengpedersen, P. Mean time parameters in pharmacokinetics. Clinical Pharmacokinetics 17:424-440, 1989.
  24. Wiest, D.B., R.L. Yost, W. Oneal, J.R. Reigart, P.C. Gillette and R.C. Brundage. Pharmacokinetics of Ranitidine in critically ill infants. Developmental Pharmacology and Therapeutics 12:7-12, 1989.
  25. Yeun, G.J., E.S. Caplan, A. Forrest, G.L. Drusano and K. Plaisance. Prospective use of optimal sampling theory-steady state Ciprofloxacin pharmacokinetics in critically ill trauma patients. Clinical Pharmacology and Therapeutics 46:451-457, 1989.